Mettler-Toledo (NYSE: MTD) leader sells 240 shares after option exercise

Q: What insider transaction did Mettler-Toledo (MTD) executive Gerry Keller report?

Gerry Keller reported exercising 240 stock options at $720.81 per share and then selling 240 common shares at $1,427.14 per share on August 3, 2026, in a combined exercise-and-sale sequence.

Q: How many Mettler-Toledo (MTD) options and shares were involved in Gerry Keller’s Form 4?

The filing shows 240 options exercised into 240 common shares, followed by a sale of 240 shares . After the derivative transaction, 235 options from the reported grant remain outstanding according to the option-holdings line.

Q: At what prices did Gerry Keller transact Mettler-Toledo (MTD) stock and options?

Keller exercised options with a $720.81 per-share exercise price and sold the resulting common shares at $1,427.14 per share . These per-share figures come directly from the reported exercise and sale transactions on August 3, 2026.

Q: What is Gerry Keller’s role at Mettler-Toledo (MTD) in this Form 4?

Gerry Keller is identified as Head of Process Analytics at Mettler-Toledo International. The Form 4 reports his option exercise and subsequent common stock sale in that capacity as a company officer, not as a director or 10% owner.

Q: Were Gerry Keller’s Mettler-Toledo (MTD) trades under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not marked as a plan transaction , indicating these trades were not reported as executed under a pre-arranged Rule 10b5-1 trading plan based on the document-level affirmation field.

Q: How did Gerry Keller’s Mettler-Toledo (MTD) option grant vest?

A footnote explains the options vested annually in five equal installments , beginning on the first anniversary of the grant date. The reported exercise on August 3, 2026, relates to this multi-year vesting schedule and remaining 235 options from the grant.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Mettler-Toledo International executive Gerry Keller, Head of Process Analytics, exercised stock options covering 240 shares of common stock at an exercise price of $720.81 per share on August 3, 2026, then sold 240 common shares at $1,427.14 per share the same day. After this exercise, 235 options from the reported grant remain outstanding; the options vest annually in five equal installments and the transactions were not reported as made under a Rule 10b5-1 trading plan.

Insider Trade Summary

Exercise and Sale: 240 shares ($170K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Keller Gerry

Role Head of Process Analytics

Sold 240 shs ($343K)

Approx. gross sale proceeds $343K

Approx. exercise cost $173K

Approx. pre-tax spread $170K

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy) ^F1	240	$0.00	$0.00
Exercise	Common Stock, par value $0.01 per share	240	$720.81	$173K
Sale	Common Stock, par value $0.01 per share	240	$1,427.14	$343K

Holdings After Transaction: Stock Option (right to buy) — 235 shares (Direct); Common Stock, par value $0.01 per share — 259 shares (Direct)

Footnotes (1)

F1. The options vested annually in five equal installments beginning on the first anniversary of the date of grant.

Key Figures

Options Exercised: 240 shares Exercise Price: $720.81 per share Shares Sold: 240 shares +4 more

7 metrics

Options Exercised 240 shares Stock options exercised into common stock on August 3, 2026

Exercise Price $720.81 per share Exercise price of stock options converted into common shares

Shares Sold 240 shares Common stock sale reported on August 3, 2026

Sale Price $1,427.14 per share Per-share price for the reported common stock sale

Options Remaining 235 options Stock options remaining from the reported grant after the exercise

Option Exercise Date 2020-11-07 Grant’s option exercise date reported for the derivative security

Option Expiration Date 2029-11-07 Expiration date of the stock option grant

Key Terms

Stock Option (right to buy), Exercise or conversion of derivative security, Common Stock, par value $0.01 per share, Rule 10b5-1 trading plan

4 terms

Stock Option (right to buy) financial

"security_title: Stock Option (right to buy)"

Exercise or conversion of derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

Rule 10b5-1 trading plan regulatory

"transactions were made pursuant to a 10b5-1 or pre-arranged trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/05/2026 - 09:37 AM Accepted by SEC EDGAR 08/05/2026 - 09:37 AM

FAQ

What insider transaction did Mettler-Toledo (MTD) executive Gerry Keller report?

Gerry Keller reported exercising 240 stock options at $720.81 per share and then selling 240 common shares at $1,427.14 per share on August 3, 2026, in a combined exercise-and-sale sequence.

How many Mettler-Toledo (MTD) options and shares were involved in Gerry Keller’s Form 4?

The filing shows 240 options exercised into 240 common shares, followed by a sale of 240 shares. After the derivative transaction, 235 options from the reported grant remain outstanding according to the option-holdings line.

At what prices did Gerry Keller transact Mettler-Toledo (MTD) stock and options?

Keller exercised options with a $720.81 per-share exercise price and sold the resulting common shares at $1,427.14 per share. These per-share figures come directly from the reported exercise and sale transactions on August 3, 2026.

What is Gerry Keller’s role at Mettler-Toledo (MTD) in this Form 4?

Gerry Keller is identified as Head of Process Analytics at Mettler-Toledo International. The Form 4 reports his option exercise and subsequent common stock sale in that capacity as a company officer, not as a director or 10% owner.

Were Gerry Keller’s Mettler-Toledo (MTD) trades under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not marked as a plan transaction, indicating these trades were not reported as executed under a pre-arranged Rule 10b5-1 trading plan based on the document-level affirmation field.

How did Gerry Keller’s Mettler-Toledo (MTD) option grant vest?

A footnote explains the options vested annually in five equal installments, beginning on the first anniversary of the grant date. The reported exercise on August 3, 2026, relates to this multi-year vesting schedule and remaining 235 options from the grant.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Keller Gerry

(Last)

(First)

(Middle)

IM LANGACHER 44

(Street)

GREIFENSEE

8606

(City)

(State)

(Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
METTLER TOLEDO INTERNATIONAL INC/ [ MTD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Head of Process Analytics

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.01 per share	08/03/2026		M		240	A	$720.81	499	D
Common Stock, par value $0.01 per share	08/03/2026		S		240	D	$1,427.14	259	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$720.81	08/03/2026		M			240	11/07/2020⁽¹⁾	11/07/2029	Common Stock, par value $0.01 per share	240	$0	235	D

Explanation of Responses:

1. The options vested annually in five equal installments beginning on the first anniversary of the date of grant.

	Michelle M. Roe, Attorney in Fact	08/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR